Financial News

Medicines' inclisiran expected to outsell bemepedoic acid

Analysts expect The Medicines Company's (Nasdaq: MDCO) inclisiran to outsell Esperion Therapeutics Inc.'s (Nasdaq: ESPR) bemepedoic acid. Shares of The Medicines Company soared $3.98 to close at $28.81 while Esperion stock added 73 cents to close at $77.93.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback